Caption Management, LLC Biomarin Pharmaceutical Inc Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

A detailed history of Caption Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Caption Management, LLC holds 42,500 shares of BMRN stock, worth $2.79 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

42,500

Previous 47,700 10.9%

Holding current value

$2.79 Million

Previous $3.93 Million 23.94%

% of portfolio

0.05%

Previous 0.06%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $1.88 Million - $2.56 Million	27,300 New	27,300 $1.92 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $808,682 - $955,251	9,649 Added 72.66%	22,929 $2 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $1.01 Million - $1.31 Million	13,280 New	13,280 $1.28 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $7.27 Million - $8.41 Million	83,872 Added 279.57%	113,872 $9.87 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $2.63 Million - $3.52 Million	30,000 New	30,000 $2.92 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $220,873 - $268,366	3,090 Added 18.84%	19,495 $1.62 Million
Q1 2022 May 13, 2022	BUY	$74.28 - $92.69 $1.22 Million - $1.52 Million	16,405 New	16,405 $1.26 Million
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $1.92 Million - $2.15 Million	-25,399 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $1.87 Million - $2.27 Million	24,997 Added 6218.16%	25,399 $1.92 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $2.17 Million - $2.7 Million	-29,898 Reduced 98.67%	402 $35,000
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $2.64 Million - $4.81 Million	-36,688 Reduced 54.77%	30,300 $2.31 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $5.01 Million - $7.82 Million	62,988 Added 1574.7%	66,988 $8.26 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $842,500 - $1.06 Million	-12,500 Reduced 75.76%	4,000 $269,000
Q2 2019 Aug 13, 2019	SELL	$80.35 - $93.9 $490,134 - $572,790	-6,100 Reduced 26.99%	16,500 $1.41 Million
Q1 2019 May 14, 2019	SELL	$84.2 - $98.62 $202,080 - $236,688	-2,400 Reduced 9.6%	22,600 $2.01 Million
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $2.02 Million - $2.38 Million	25,000	25,000 $2.23 Million

Others Institutions Holding BMRN

# of Institutions

629

Shares Held

178M

Call Options Held

1.98M

Put Options Held

1.17M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account

Caption Management, LLC Biomarin Pharmaceutical Inc Transaction History